Inventor
CHANDY K GEORGE
US11 patents
Patents
11 patentsUS6165719ADec 26, 2000
hKCa3/KCNN3 small conductance calcium activated potassium channel: a diagnostic marker and therapeutic target
UNIV CALIFORNIA17 citations89
US6803375B1Oct 12, 2004
Non-peptide inhibition of T-lymphocyte activation and therapies related thereto
UNIV CALIFORNIA4 citations60
US6653100B1Nov 25, 2003
hKCa3/KCNN3 small conductance calcium activated potassium channel: A diagnostic marker and therapeutic target
UNIV CALIFORNIA4 citations59
US9616102B2Apr 11, 2017
Analogs of ShK toxin and their uses in selective inhibition of Kv1.3 potassium channels
UNIV CALIFORNIA1 citations57
US9061071B2Jun 23, 2015
Analogs of ShK toxin and their uses in selective inhibition of Kv1.3 potassium channels
UNIV CALIFORNIA2 citations57
US7772408B1Aug 10, 2010
Substituted 5-alkoxypsoralens as inhibitors of potassium channel activity in lymphocytes and other cells
UNIV CALIFORNIA6 citations54
US7378496B2May 27, 2008
hKCa3/KCNN3 small conductance calcium activated potassium channel: a diagnostic marker and therapeutic target
UNIV CALIFORNIA0 citations49
US7235577B1Jun 26, 2007
Non-peptide inhibition of T-lymphocyte activation and therapies related thereto
UNIV CALIFORNIA1 citations49
US8026263B2Sep 27, 2011
Methods for inhibiting neoproliferative changes in blood vessel walls
UNIV CALIFORNIA1 citations46
US7022480B1Apr 4, 2006
Exons of the hSKCa3/KCNN3 gene
UNIV CALIFORNIA0 citations46
US9878006B2Jan 30, 2018
Treatment of obesity and obesity related disorders by pharmalogical targeting of Kv1.3 potassium channels
UNIV CALIFORNIA0 citations36